Back

Combining fractional flow reserve and the index of microcirculatory resistance for prognosis prediction in renal artery stenosis interventions: a feasibility sub-study of FAIR-pilot trial

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Hypertension: miscellaneous aspects Secondary Hypertension ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Xu Liu

Beijing (China)

7 More presentations in this session

Presentation thumbnail
Impact of appendicular skeletal muscle mass on effect of intensive blood pressure control
Doctor X. Wang (Calgary, CA)
Abstract Slides Video
Presentation thumbnail
Central systolic blood pressure, augmentation index and pulse pressure amplification in pregnancy hypertension and their possible role for earlier detection of preeclampsia
Slides Video
Presentation thumbnail
Application of the 2016 ase-eacvi criteria for the assessment of diastolic function in arterial hypertension
Mrs G. Canciello (Napoly, IT)
Abstract Slides Video
Presentation thumbnail
More hypertensive crises in women than in men in a single emergency department
Doctor E. Strzelczyk (Munich, DE)
Abstract Slides Video
Presentation thumbnail
Higher systolic blood pressure in left not right upper limb is associated with all-cause mortality risk in a community-based population
Doctor F. Fan (Beijing, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Hypertension: miscellaneous aspects

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Index of microvascular resistance (IMR) and fractional flow reserve (FFR) relationship in patients with angina and non-obstructive coronary artery (ANOCA) disease
thumbnail
Congress Presentation
Elevated index of microcirculatory resistance predicts vascular adverse events in high-risk patients
thumbnail
Congress Presentation
Microvascular functional assessment using microvascular resistance reserve in patients undergoing elective fractional flow reserve-guided percutaneous coronary intervention

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources